Medical and Biopharma Research

Research Overview

Author: Michael Scott
Release Date: December 11, 2017

Abstract:

The healthcare systems of many countries work for neither healthcare professionals nor their patients. This research examines how we can fix healthcare by applying a new set of principles—collaboration, openness, and integrity—to medical research and clinical trials.

Copyright 2017 Blockchain Research Institute – not for distribution

The Medical and Biopharma Infographic

Copyright 2017 Blockchain Research Institute ™.
This infographic is exclusively available for distribution to employees of BRI member organization.

Related Content

Web3 in the Pharmaceutical Industry

For decades, productivity and innovation in the pharmaceutical industry have declined. It has been slow to transform digitally and culturally. This research describes how executives can lead change by harnessing Web3 technologies. The payoffs will be greater internal rates of return on drug discovery and personalized medicine, and more efficient and secure clinical trials and supply chains among other significant benefits.

Read More

Web 3 and the Music Industry

In this project, our research lead reviews what we learned from the music industry’s first wave of blockchain innovation and explores the opportunities in its second wave, including innovations such as non-fungible tokens and metaverse experiences. He looks at the barriers to realizing these opportunities, including risks such as the legal grey area around who holds the intellectual property rights to minting music-related NFTs. He includes excerpts of his in-depth interviews of Scott Cohen, former chief innovation officer, Warner Music Group; Sophie Goossens, partner, Reed Smith; Vaughn McKenzie-Landell, CEO and co-founder of JAAK; and Christof Straub, CEO and founder, Global Rockstar.

Read More
Subscribe